Abstract 81P
Background
mFOLFOX6 concurrent radiotherapy in the FOWARC study led to 27% of pCR rate in locally advanced rectal cancer (LARC). The total neoadjuvant treatment study (CAO/ARO/AIO-12) had compared the efficacy of chemoradiotherapy plus induction or consolidation chemotherapy. The result showed that consolidation chemotherapy led to higher pCR rate than that of induction chemotherapy. Here, we aimed to compare the efficacy of preoperative concurrent mFOLFOX6 chemoradiotherapy versus concurrent and consolidation chemotherapy during radiation as neoadjuvant treatment in locally advanced rectal cancer.
Methods
Prospectively maintained databases of patients from two clinical trials ( NCT01211210 and NCT02217020) underwent preoperative treatment for locally advanced rectal cancer were included. 143 patients received concurrent mFOLFOX6 chemoradiotherapy and TME surgery. 123 patients received concurrent and consolidation chemotherapy during radiation before TME. A comparative analysis was performed after the implementation of propensity score matching on the 2 main cohorts.
Results
A total of 266 patients were enrolled in the study. After propensity score matching, 180 patients were selected. 113 patients were comparable in the two groups. The pathologic complete response rate was comparable between the two groups (27.1% vs. 27.9%). And the tumor downstaging rate was also similar between the two groups (54.1vs. 59.1%). The compliance of chemotherapy was much better in concurrent chemoradiotherapy with mFOLFOX6 (93.5% vs. 39.5%). Higher incidence of grade 3/4neutropenia (16.1% vs. 30.1%, P < 0.01) was shown in concurrent chemoradiotherapy group than that of concurrent and consolidation chemoradiotherapy group.
Conclusions
Preoperative concurrent chemoradiotherapy with mFOLFOX6 showed similar efficacy with radiotherapy plus consolidation chemotherapy and higher compliance of chemotherapy. Long-term follow-up will assess whether the higher compliance would translates to better oncologic outcome.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Yanhong Deng.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
144P - Severe hypovitaminosis D in metastatic gastric cancer patients from the Northern and Southern hemispheres: Data from the EXPAND phase III trial
Presenter: Radka Obermannova
Session: Poster display session
Resources:
Abstract
145P - Role of Glasgow prognostic score in chemo-naïve patients with advanced biliary tract cancer and good performance status
Presenter: Toshikazu Moriwaki
Session: Poster display session
Resources:
Abstract
146P - Anatomic versus non-anatomic resection for hepatocellular carcinoma: A meta-analysis of high-quality studies
Presenter: Bin Zhang
Session: Poster display session
Resources:
Abstract
147P - Clinical outcomes of proximal gastrectomy versus total gastrectomy for locally advanced proximal gastric cancer: a propensity score matching analysis
Presenter: Yingtai Chen
Session: Poster display session
Resources:
Abstract
148P - Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
Presenter: Seunghwan Lee
Session: Poster display session
Resources:
Abstract
150P - A Phase Ib Study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction
Presenter: Yee Chao
Session: Poster display session
Resources:
Abstract
151P - Gene expression profiling for a better understanding of gastric cancer: From the perspective of metabolic rearrangement
Presenter: Midie Xu
Session: Poster display session
Resources:
Abstract
152P - Long-term outcomes of three-dimensional conformal radiotherapy-based and intensity-modulated radiotherapy-based concurrent chemoradiotherapy in patients with thoracic esophageal squamous cell carcinoma
Presenter: Chia-Lun Chang
Session: Poster display session
Resources:
Abstract
153P - Exosomal LINC00174 facilitates epithelial-mesenchymal transition in residual hepatocellular carcinoma after insufficient radiofrequency ablation by regulating c-JUN/MYCBP/c-Myc axis
Presenter: Dening Ma
Session: Poster display session
Resources:
Abstract
154P - Genetic characteristics of participants in the Australian Pancreatic Screening Study
Presenter: Krithika Murali
Session: Poster display session
Resources:
Abstract